Oct 29, 2026 · 9 min
Earnings expose diverging bets on AI and healthcare demand
Alphabet Falls, Caterpillar Slumps, Eli Lilly Rises After Raising Sales Forecast
The market reactions show how investor expectations can outweigh headline earnings results, especially when growth depends on AI spending or fast-rising drug demand.
- 1Alphabet’s weaker search and advertising growth raised questions about the payoff and pressure surrounding its AI investments.
- 2Caterpillar’s modest earnings beat fell short of expectations shaped by enthusiasm for companies supplying AI infrastructure.
- 3Eli Lilly’s raised sales forecast reflected strong demand for obesity and diabetes treatments, sending its shares higher.
Don't miss
Eli Lilly raises its sales forecast on strong obesity and diabetes treatment demand, contrasting sharply with the episode’s technology declines.
The brief
The episode opens with a preview of smart-city infrastructure before turning to a fast Bloomberg roundup of companies moving markets after quarterly results.
Alphabet fell as weaker search and advertising growth challenged the optimism around its AI investments, making expectations as important as the reported numbers.
Caterpillar also declined despite a modest earnings beat, as investor expectations tied to AI infrastructure left little room for an ordinary result.
Eli Lilly moved in the opposite direction after raising its sales forecast, with strong demand for obesity and diabetes treatments driving the brighter outlook.
A later Bloomberg Tech Minute shifts from earnings to SpaceX, where exceptional ability, loyalty, and commitment to Elon Musk’s vision shape the hiring culture.
Together, the moves show how markets reward evidence of durable demand while punishing results that fail to match an elevated growth narrative.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.